{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:36:20Z","timestamp":1773866180681,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T00:00:00Z","timestamp":1543276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Willy Gepts, UZ Brussel"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10815-018-1372-5","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T04:15:06Z","timestamp":1543292106000},"page":"491-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Rare genetic variants potentially involved in ovarian hyperstimulation syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Katrien","family":"Stouffs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Daelemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Santos-Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Seneca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Gheldof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Sami","family":"G\u00fcrb\u00fcz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Tournaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Blockeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,27]]},"reference":[{"key":"1372_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/humupd\/dmg005","volume":"9","author":"A Delvigne","year":"2003","unstructured":"Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9:77\u201396.","journal-title":"Hum Reprod Update"},{"key":"1372_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.fertnstert.2011.12.046","volume":"97","author":"SR Soares","year":"2012","unstructured":"Soares SR, Amols MH, Hudson SBA, et al. Etiology of OHSS and use of dopamine agonists. Fertil Steril. 2012;97:517\u201322.","journal-title":"Fertil Steril"},{"key":"1372_CR3","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.fertnstert.2015.02.004","volume":"103","author":"HM Fatemi","year":"2015","unstructured":"Fatemi HM, Garcia-Velasco J. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger. Fertil Steril. 2015;103:870\u20133.","journal-title":"Fertil Steril"},{"key":"1372_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/humupd\/3.3.255","volume":"3","author":"B Rizk","year":"1997","unstructured":"Rizk B, Aboulghar M, Smitz J, Ron-El R. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum Reprod Update. 1997;3:255\u201366.","journal-title":"Hum Reprod Update"},{"key":"1372_CR5","first-page":"1967","volume":"80","author":"J Neulen","year":"1995","unstructured":"Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor\/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 1995;80:1967\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"1372_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.10028","volume":"33","author":"JW Walter","year":"2002","unstructured":"Walter JW, North PE, Waner M, Mizeracki A, Blei F, Walker JWT, et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer. 2002;33:295\u2013303.","journal-title":"Genes Chromosomes Cancer"},{"key":"1372_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1472-6483(10)60040-5","volume":"19","author":"A Delvigne","year":"2009","unstructured":"Delvigne A. Epidemiology of OHSS. Reprod BioMed Online. 2009;19:8\u201313.","journal-title":"Reprod BioMed Online"},{"key":"1372_CR8","doi-asserted-by":"publisher","unstructured":"Berkkanoglu M, Coetzee K, Bulut H, Ozgur K. Risk of ovarian torsion is reduced in GnRH agonist triggered freeze-all cycles: a retrospective cohort study. J Obstet Gynaecol. 2018:1\u20136. \n                    https:\/\/doi.org\/10.1080\/01443615.2018.1479381\n                    \n                  .","DOI":"10.1080\/01443615.2018.1479381"},{"key":"1372_CR9","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"G Griesinger","year":"2011","unstructured":"Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a \u201cfreeze-all\u201d strategy: a prospective multicentric study. Fertil Steril. 2011;95:2029\u201333.","journal-title":"Fertil Steril"},{"key":"1372_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.fertnstert.2014.01.019","volume":"101","author":"HM Fatemi","year":"2014","unstructured":"Fatemi HM, Popovic-Todorovic B, Humaidan P, Kol S, Banker M, Devroey P, et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and \u201cfreeze-all\u201d approach in GnRH antagonist protocol. Fertil Steril. 2014;101:1008\u201311.","journal-title":"Fertil Steril"},{"key":"1372_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.rbmo.2014.07.022","volume":"29","author":"AS Gurbuz","year":"2014","unstructured":"Gurbuz AS, Gode F, Ozcimen N, Isik AZ. Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases. Reprod BioMed Online. 2014;29:541\u20134.","journal-title":"Reprod BioMed Online"},{"key":"1372_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S1028-4559(09)60196-0","volume":"45","author":"S-Y Ling","year":"2006","unstructured":"Ling S-Y, Chong K-M, Hwang J-L. Persistent megalocystic ovary following in vitro fertilization in a postpartum patient with polycystic ovarian syndrome. Taiwan J Obstet Gynecol. 2006;45:70\u20132.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1372_CR13","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s10815-015-0498-y","volume":"32","author":"S Santos-Ribeiro","year":"2015","unstructured":"Santos-Ribeiro S, Polyzos NP, Stouffs K, de Vos M, Seneca S, Tournaye H, et al. Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and \u201cfreeze-all\u201d: in-depth analysis of genetic predisposition. J Assist Reprod Genet. 2015;32:1063\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"1372_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1210\/jc.2003-031910","volume":"89","author":"L Montanelli","year":"2004","unstructured":"Montanelli L, Delbaere A, Di Carlo C, et al. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 2004;89:1255\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1372_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/humupd\/dmr034","volume":"17","author":"S Altm\u00e4e","year":"2011","unstructured":"Altm\u00e4e S, Hovatta O, Stavreus-Evers A, Salumets A. Genetic predictors of controlled ovarian hyperstimulation: where do we stand today? Hum Reprod Update. 2011;17:813\u201328.","journal-title":"Hum Reprod Update"},{"key":"1372_CR16","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2217\/pgs.14.49","volume":"15","author":"B Lledo","year":"2014","unstructured":"Lledo B, Ortiz JA, Llacer J, Bernabeu R. Pharmacogenetics of ovarian response. Pharmacogenomics. 2014;15:885\u201393.","journal-title":"Pharmacogenomics"},{"key":"1372_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108287","volume":"9","author":"R Boudjenah","year":"2014","unstructured":"Boudjenah R, Molina-Gomes D, Torre A, Boitrelle F, Taieb S, Dos Santos E, et al. Associations between individual and combined polymorphisms of the TNF and VEGF genes and the embryo implantation rate in patients undergoing in vitro fertilization (IVF) programs. PLoS One. 2014;9:e108287.","journal-title":"PLoS One"},{"key":"1372_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038700","volume":"7","author":"R Boudjenah","year":"2012","unstructured":"Boudjenah R, Molina-Gomes D, Torre A, Bergere M, Bailly M, Boitrelle F, et al. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoS One. 2012;7:e38700.","journal-title":"PLoS One"},{"key":"1372_CR19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/01.fpc.0000215073.44589.96","volume":"16","author":"FJ Mor\u00f3n","year":"2006","unstructured":"Mor\u00f3n FJ, de Castro F, Royo JL, Montoro L, Mira E, S\u00e1ez ME, et al. Bone morphogenetic protein 15 (BMP15) alleles predict over-response to recombinant follicle stimulation hormone and iatrogenic ovarian hyperstimulation syndrome (OHSS). Pharmacogenet Genomics. 2006;16:485\u201395.","journal-title":"Pharmacogenet Genomics"},{"key":"1372_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1477-7827-11-71","volume":"11","author":"TJ O\u2019Brien","year":"2013","unstructured":"O\u2019Brien TJ, Kalmin MM, Harralson AF, Clark AM, Gindoff I, Simmens SJ, et al. Association between the luteinizing hormone\/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation. Reprod Biol Endocrinol. 2013;11:71.","journal-title":"Reprod Biol Endocrinol"},{"key":"1372_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1472-6483(10)60041-7","volume":"19","author":"B Rizk","year":"2009","unstructured":"Rizk B. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome. Reprod Biomed Online. 2009;19:14\u201327.","journal-title":"Reprod Biomed Online"},{"key":"1372_CR22","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jvs.2017.02.034","volume":"67","author":"R Mattassi","year":"2018","unstructured":"Mattassi R, Manara E, Colombo PG, Manara S, Porcella A, Bruno G, et al. Variant discovery in patients with Mendelian vascular anomalies by next-generation sequencing and their use in patient clinical management. J Vasc Surg. 2018;67:922\u2013932.e11.","journal-title":"J Vasc Surg"},{"key":"1372_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/onc.2010.451","volume":"30","author":"C-C Hsu","year":"2011","unstructured":"Hsu C-C, Chiang C-W, Cheng H-C, Chang WT, Chou CY, Tsai HW, et al. Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach. Oncogene. 2011;30:654\u201367.","journal-title":"Oncogene"},{"key":"1372_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/humupd\/dmn008","volume":"14","author":"SR Soares","year":"2008","unstructured":"Soares SR, G\u00f3mez R, Sim\u00f3n C, Garc\u00eda-Velasco JA, Pellicer A. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum Reprod Update. 2008;14:321\u201333.","journal-title":"Hum Reprod Update"},{"key":"1372_CR25","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1095\/biolreprod.102.010801","volume":"68","author":"R G\u00f3mez","year":"2003","unstructured":"G\u00f3mez R, Sim\u00f3n C, Remoh\u00ed J, Pellicer A. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability1. Biol Reprod. 2003;68:2164\u201371.","journal-title":"Biol Reprod"},{"key":"1372_CR26","first-page":"253","volume":"17","author":"F Bahram","year":"2010","unstructured":"Bahram F, Claesson-Welsh L. VEGF-mediated signal transduction in lymphatic endothelial cells. Pathophysiol Off J Int Soc Pathophysiol. 2010;17:253\u201361.","journal-title":"Pathophysiol Off J Int Soc Pathophysiol"},{"key":"1372_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1161\/CIRCRESAHA.116.310477","volume":"120","author":"K Heinolainen","year":"2017","unstructured":"Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, et al. VEGFR3 modulates vascular permeability by controlling VEGF\/VEGFR2 signaling. Circ Res. 2017;120:1414\u201325.","journal-title":"Circ Res"},{"key":"1372_CR28","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/84651","volume":"7","author":"T M\u00e4kinen","year":"2001","unstructured":"M\u00e4kinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199\u2013205.","journal-title":"Nat Med"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1372-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10815-018-1372-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-018-1372-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:10:24Z","timestamp":1574813424000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10815-018-1372-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,27]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1372"],"URL":"https:\/\/doi.org\/10.1007\/s10815-018-1372-5","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,27]]},"assertion":[{"value":"25 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for the study was received from the Ethics Committee of the UZ Brussel (EC2916\/67).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}